Hooper, David K <br/><br/>
Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation.  [electronic resource] 

 -  Transplantation  Apr 2012 
 - 806-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0b013e318247a6c7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antihypertensive Agents--therapeutic use<br/>Child<br/>Cytochrome P-450 CYP3A--genetics<br/>Female<br/>Humans<br/>Hypertension--drug therapy<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Transplantation<br/>Male<br/>Nicardipine--therapeutic use<br/>Risk<br/>Tacrolimus--adverse effects<br/>Young Adult